Skip to main content
. 2012 Dec 20;168(2):458–470. doi: 10.1111/j.1476-5381.2012.02145.x

Table 1.

Monoamine transporter and receptor binding affinities

NET DAT SERT 5-HT1A 5-HT2A 5-HT2C α1A α2A D1 D2 D3 H1 TA1rat TA1mouse
MDMA 30.5 ± 8.0 6.5 ± 2.5 13.3 ± 0.6 12.2 ± 0.8 7.8 ± 2.4 >13 >6 15.0 ± 10 >13.6 25.2 ± 12 >17.7 >14.4 0.37 ± 0.12 2.4 ± 1.1
MBDB 11.9 ± 1.4 3.1 ± 0.3 5.80 ± 0.7 15.5 ± 3.8 6.62 ± 1.8 >13 >6 16.9 ± 4 >12.5 NA >16 >13 1.2 ± 0.1 3.6 ± 1.1
MDEA 6.17 ± 1.4 1.35 ± 0.06 4.32 ± 0.6 18.8 ± 0.78 >13 >13 >6 12.2 ± 0.5 >12.5 NA >16 >13 0.32 ± 0.6 4.9 ± 1.7
Ethylone 9.89 ± 0.9 1.43 ± 0.4 9.04 ± 0.6 17.0 ± 2.4 >13 >13 >6 >25 >12.5 NA >16 >13 >12.5 >10
Mephedrone >25 3.4 ± 0.8 >30 >20 2.1 ± 0.7 >13 3.48 ± 2.2 11.0 ± 5.0 >13.6 >30 >9.2 >14.4 4.3 ± 2.0 >10
Naphyrone 0.18 ± 0.02 0.04 ± 0.01 0.18 ± 0.02 6.00 ± 0.21 11 ± 2.2 >13 >6 8.0 ± 2.8 >12.5 NA >16 2.28 ± 0.27 >12.5 >10
Butylone 8.13 ± 0.7 0.44 ± 0.03 14.1 ± 4.1 >20 >13 >13 >6 >25 >12.5 NA >16 >13 >12.5 >10
Cocaine 4.47 ± 2.6 0.28 ± 0.07 1.1 ± 0.09 >20 >13 >13 >6 >20 >13.6 >30 >17.7 >14.4 >10 >10
Methylone >25 2.73 ± 0.2 >30 >20 >13 >13 >6 >20 >13.6 >30 >9.2 >14.4 >12.5 >10
Flephedrone >25 12.2 ± 3.1 >30 >20 1.4 ± 0.6 >13 1.52 ± 0.05 >20 >13.6 >30 >17.7 >14.4 5.4 ± 1.7 >10
Cathinone 3.50 ± 2.7 19.8 ± 1.9 >30 >20 >13 >13 5.40 ± 1.1 8.9 ± 2.7 >13.6 >30 >17.7 >14.4 2.2 ± 0.70 2.1 ± 0.73
Methcathinone 1.45 ± 0.7 1.28 ± 0.2 >30 12.7 ± 3.5 3.0 ± 0.6 >13 3.93 ± 1.3 11.9 ± 3.9 >13.6 >30 >9.2 >14.4 4.1 ± 1.2 >10
Amphetamine 1.00 ± 0.6 5.68 ± 3.8 >25 6.74 ± 1.38 >13 >13 >6 2.8 ± 0.8 >13.6 >30 >17.7 >14.4 0.23 ± 0.18 0.09 ± 0.06
Methamphetamine 4.28 ± 2.1 1.85 ± 0.9 26.7 ± 11 8.07 ± 0.75 >13 >13 >6 6.1 ± 1.6 >13.6 >30 >17.7 >14.4 0.35 ± 0.12 0.55 ± 0.2
Pyrovalerone 0.06 ± 0.005 0.03 ± 0.005 4.97 ± 0.3 13.4 ± 2.1 >13 >13 >6 >20 >13.6 >30 >9.2 10.7 ± 1.5 >12.5 >10
MDPV 0.08 ± 0.02 0.01 ± 0.002 2.86 ± 0.1 10.29 ± 4.7 >13 >13 >6 >20 >13.6 >30 >9.2 >14.4 7.2 ± 1.1 >10

Values are Ki given as μM (mean ± SD).

NA, not assessed.